A nanodiamond chemotherapeutic folate receptor-targeting prodrug with triggerable drug release

Authors

Jiangtao Wu, School of Chemistry and Chemical Engineering, Shanxi University, Taiyuan
Xiangbin Du, School of Chemistry and Chemical Engineering, Shanxi University, Taiyuan
Dongmei Zhang, Taiyuan Central Hospital, Taiyuan
Jicheng Cui, Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Institute of Molecular Science, Shanxi University, Taiyuan
Xiaoxia Zhang, School of Chemistry and Chemical Engineering, Shanxi University, Taiyuan
Xine Duan, School of Chemistry and Chemical Engineering, Shanxi University, Taiyuan
John F. Trant, Department of Chemistry and Biochemistry, University of Windsor, 401 Sunset Ave, Windsor, ONFollow
Yingqi Li, School of Chemistry and Chemical Engineering, Shanxi University, Taiyuan

Document Type

Article

Publication Date

11-28-2022

Publication Title

International Journal of Pharmaceutics

Volume

630

First Page

122432

Keywords

Targeted delivery, Controlled drug release, Chemotherapy, Doxorubicin, Drug-resistance

DOI

10.1016/j.ijpharm.2022.122432

ISSN

0378-5173

Recommended Citation

Wu, Jiangtao; Du, Xiangbin; Zhang, Dongmei; Cui, Jicheng; Zhang, Xiaoxia; Duan, Xine; Trant, John F.; and Li, Yingqi. (2022). A nanodiamond chemotherapeutic folate receptor-targeting prodrug with triggerable drug release. International Journal of Pharmaceutics, 630, 122432.
https://scholar.uwindsor.ca/chemistrybiochemistrypub/336